LÜTHY IA

Mecanismo de acción de receptores de esteroides.

Fisiopatología Molecular y Clínica Endocrinológica

Lugar: Ciudad Autónoma de Buenos Aires; Año: 2015; p. 161 - 171

MOLINOLO AA; PAZOS P; MONTECCHIA MF; KORDON EC; DRAN G; GUERRA F; ELIZALDE P; LÜTHY IA; CHARREAU EH; DOSNE PASQUALINI C; LANARI C

Pathogenesis of ductal and lobular progestin-induced mammary carcinomas in BALB/c mice

Hormonal Carcinogenesis II

Lugar: Nueva York; Año: 1996; p. 141 - 147

LABRIE F; DUPONT A; BÉLANGER A; SIMARD J,; LABRIE C; POULIN R; LÜTHY IA; VEUILLEUX R; LACOSTE D; MARCHETTI B; CUSAN L; MANHES G; MONFETTE G; EMOND J

Combination therapy with the antiandrogen Flutamide and the LHRH agonist [D-Trp6, des-Gly-NH210]LHRH ethylamide in prostate cancer: rationale and 5-year clinical experience.

Molecular biology of Brain and Endocrine Peptidergic Systems

Lugar: Nueva York; Año: 1988; p. 83 - 101

LABRIE F; BÉLANGER A; VEUILLEUX R; LACOSTE D; LABRIE C; MARCHETTI B; POULIN R; DUPONT A; CUSAN L; LÜTHY IA

Rationale for maximal androgen withdrawal in the therapy of prostate cancer

Baillière's Clinical Oncology on Prostatic Cancer

Lugar: Londres; Año: 1988; p. 597 - 619

LABRIE F; DUPONT A; BÉLANGER A; EMOND J; MONFETTE G; LÜTHY IA; SIMARD J,; LACHANCE R

Flutamide in combination with castration (surgical or medical) is the standard treatment in advanced prostate cancer

Journal of Drug Development

Año: 1987; p. 34 - 51

BARAÑAO JL; TESONE M; CALVO JC; LÜTHY IA; GONZÁLEZ SI; CHARREAU EH; CALANDRA RS

Prolactin effects on the prepubertal male rat

Recent advances in male reproduction: molecular basis and clinical implications

Lugar: Nueva York; Año: 1983; p. 305 - 312